- Home
- TMDX vs ALE Comparison
TMDX vs ALE Comparison
Compare TMDX & ALE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMDX
- ALE
- Stock Information
- Founded
- TMDX 1998
- ALE 1906
- Country
- TMDX United States
- ALE United States
- Employees
- TMDX N/A
- ALE N/A
- Industry
- TMDX Biotechnology: Electromedical & Electrotherapeutic Apparatus
- ALE Power Generation
- Sector
- TMDX Health Care
- ALE Utilities
- Exchange
- TMDX Nasdaq
- ALE Nasdaq
- Market Cap
- TMDX 4.0B
- ALE 3.8B
- IPO Year
- TMDX 2019
- ALE N/A
- Fundamental
- Price
- TMDX $130.67
- ALE $67.38
- Analyst Decision
- TMDX Buy
- ALE
- Analyst Count
- TMDX 12
- ALE 0
- Target Price
- TMDX $128.92
- ALE N/A
- AVG Volume (30 Days)
- TMDX 868.2K
- ALE 748.6K
- Earning Date
- TMDX 10-29-2025
- ALE 10-31-2025
- Dividend Yield
- TMDX N/A
- ALE 4.33%
- EPS Growth
- TMDX 2163.11
- ALE N/A
- EPS
- TMDX 2.02
- ALE 3.17
- Revenue
- TMDX $531,292,000.00
- ALE $1,532,500,000.00
- Revenue This Year
- TMDX $38.78
- ALE $2.24
- Revenue Next Year
- TMDX $20.76
- ALE $5.63
- P/E Ratio
- TMDX $64.68
- ALE $21.26
- Revenue Growth
- TMDX 48.09
- ALE N/A
- 52 Week Low
- TMDX $55.00
- ALE $62.38
- 52 Week High
- TMDX $145.50
- ALE $67.49
- Technical
- Relative Strength Index (RSI)
- TMDX 69.28
- ALE 73.27
- Support Level
- TMDX $108.34
- ALE $67.30
- Resistance Level
- TMDX $118.51
- ALE $67.45
- Average True Range (ATR)
- TMDX 6.15
- ALE 0.11
- MACD
- TMDX 1.78
- ALE -0.07
- Stochastic Oscillator
- TMDX 86.45
- ALE 54.17
About TMDX TransMedics Group Inc.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
About ALE Allete Inc.
ALLETE Inc provides competitively-priced energy in America's Upper Midwest region and invests in transmission infrastructure and other energy-centric businesses. The company has two reportable segments. The first segment is Regulated Operations, which includes the company's regulated utilities, Minnesota Power and SWL&P, as well as its investment in ATC. ATC is a regulated utility based in Wisconsin that owns and maintains electric transmission assets in parts of Wisconsin, Michigan, Minnesota, and Illinois. The second segment is ALLETE Clean Energy, which focuses on developing, acquiring, and operating clean and renewable energy projects.